|
1
|
Griffin G, Shenoi S and Hughes GC:
Hemophagocytic lymphohistiocytosis: An update on pathogenesis,
diagnosis, and therapy. Best Pract Res Clin Rheumatol.
34(101515)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Farquhar JW and Claireaux AE: Familial
haemophagocytic reticulosis. Arch Dis Child. 27:519–525.
1952.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Brisse E, Wouters CH and Matthys P:
Advances in the pathogenesis of primary and secondary
haemophagocytic lymphohistiocytosis: Differences and similarities.
Br J Haematol. 174:203–217. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Brisse E, Matthys P and Wouters CH:
Understanding the spectrum of haemophagocytic lymphohistiocytosis:
Update on diagnostic challenges and therapeutic options. Br J
Haematol. 174:175–187. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Price B, Lines J, Lewis D and Holland N:
Haemophagocytic lymphohistiocytosis: A fulminant syndrome
associated with multiorgan failure and high mortality that
frequently masquerades as sepsis and shock. S Afr Med J.
104:401–406. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bergsten E, Horne A, Aricó M, Astigarraga
I, Egeler RM, Filipovich AH, Ishii E, Janka G, Ladisch S, Lehmberg
K, et al: Confirmed efficacy of etoposide and dexamethasone in HLH
treatment: Long-term results of the cooperative HLH-2004 study.
Blood. 130:2728–2738. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Henter JI, Horne A, Aricó M, Egeler RM,
Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski
J and Janka G: HLH-2004: Diagnostic and therapeutic guidelines for
hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer.
48:124–131. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jordan MB, Allen CE, Greenberg J, Henry M,
Hermiston ML, Kumar A, Hines M, Eckstein O, Ladisch S, Nichols KE,
et al: Challenges in the diagnosis of hemophagocytic
lymphohistiocytosis: Recommendations from the North American
consortium for histiocytosis (NACHO). Pediatr Blood Cancer.
66(e27929)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ehl S, Astigarraga I, von Bahr Greenwood
T, Hines M, Horne A, Ishii E, Janka G, Jordan MB, La Rosée P,
Lehmberg K, et al: Recommendations for the use of etoposide-based
therapy and bone marrow transplantation for the treatment of HLH:
Consensus statements by the HLH steering committee of the
histiocyte society. J Allergy Clin Immunol Pract. 6:1508–1517.
2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Freeman HR and Ramanan AV: Review of
haemophagocytic lymphohistiocytosis. Arch Dis Child. 96:688–693.
2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ishii E, Ohga S, Imashuku S, Yasukawa M,
Tsuda H, Miura I, Yamamoto K, Horiuchi H, Takada K, Ohshima K, et
al: Nationwide survey of hemophagocytic lymphohistiocytosis in
Japan. Int J Hematol. 86:58–65. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cleves D, Lotero V, Medina D, Perez PM,
Patiño JA, Torres-Canchala L and Olaya M: Pediatric hemophagocytic
lymphohistiocytosis: A rarely diagnosed entity in a developing
country. BMC Pediatr. 21(411)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sieni E, Cetica V, Piccin A, Gherlinzoni
F, Sasso FC, Rabusin M, Attard L, Bosi A, Pende D, Moretta L and
Aricò M: Familial hemophagocytic lymphohistiocytosis may present
during adulthood: Clinical and genetic features of a small series.
PLoS One. 7(e44649)2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Malinowska I, Machaczka M, Popko K,
Siwicka A, Salamonowicz M and Nasiłowska-Adamska B: Hemophagocytic
syndrome in children and adults. Arch Immunol Ther Exp (Warsz).
62:385–394. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ramos-Casals M, Brito-Zerón P,
López-Guillermo A, Khamashta MA and Bosch X: Adult haemophagocytic
syndrome. Lancet. 383:1503–1516. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Macheta M, Will AM, Houghton JB and Wynn
RF: Prominent dyserythropoiesis in four cases of haemophagocytic
lymphohistiocytosis. J Clin Pathol. 54:961–963. 2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Benson LA, Li H, Henderson LA, Solomon IH,
Soldatos A, Murphy J, Bielekova B, Kennedy AL, Rivkin MJ, Davies
KJ, et al: Pediatric CNS-isolated hemophagocytic
lymphohistiocytosis. Neurol Neuroimmunol Neuroinflamm.
6(e560)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
de Kerguenec C, Hillaire S, Molinié V,
Gardin C, Degott C, Erlinger S and Valla D: Hepatic manifestations
of hemophagocytic syndrome: A study of 30 cases. Am J
Gastroenterol. 96:852–857. 2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Amir AZ, Ling SC, Naqvi A, Weitzman S,
Fecteau A, Grant D, Ghanekar A, Cattral M, Nalli N, Cutz E, et al:
Liver transplantation for children with acute liver failure
associated with secondary hemophagocytic lymphohistiocytosis. Liver
Transpl. 22:1245–1253. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Al-Samkari H and Berliner N:
Hemophagocytic lymphohistiocytosis. Annu Rev Pathol. 13:27–49.
2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ishii E: Hemophagocytic
lymphohistiocytosis in children: Pathogenesis and treatment. Front
Pediatr. 4(47)2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Skinner J, Yankey B and Shelton BK:
Hemophagocytic lymphohistiocytosis. AACN Adv Crit Care. 30:151–164.
2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Morimoto A, Nakazawa Y and Ishii E:
Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and
management. Pediatr Int. 58:817–825. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Jordan MB, Hildeman D, Kappler J and
Marrack P: An animal model of hemophagocytic lymphohistiocytosis
(HLH): CD8+ T cells and interferon gamma are essential for the
disorder. Blood. 104:735–743. 2004.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Castillo L and Carcillo J: Secondary
hemophagocytic lymphohistiocytosis and severe sepsis/systemic
inflammatory response syndrome/multiorgan dysfunction
syndrome/macrophage activation syndrome share common intermediate
phenotypes on a spectrum of inflammation. Pediatr Crit Care Med.
10:387–392. 2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Grom AA, Horne A and De Benedetti F:
Macrophage activation syndrome in the era of biologic therapy. Nat
Rev Rheumatol. 12:259–268. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Canna SW and Behrens EM: Making sense of
the cytokine storm: A conceptual framework for understanding,
diagnosing, and treating hemophagocytic syndromes. Pediatr Clin
North Am. 59:329–344. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jordan MB: Emergence of targeted therapy
for hemophagocytic lymphohistiocytosis. Hematologist. 15:2018.
|
|
29
|
Fajgenbaum DC and June CH: Cytokine storm.
N Engl J Med. 383:2255–2273. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Alonso EM, Horslen SP, Behrens EM and Doo
E: Pediatric acute liver failure of undetermined cause: A research
workshop. Hepatology. 65:1026–1037. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Henter JI, Aricò M, Egeler RM, Elinder G,
Favara BE, Filipovich AH, Gadner H, Imashuku S, Janka-Schaub G,
Komp D, et al: HLH-94: A treatment protocol for hemophagocytic
lymphohistiocytosis. HLH study group of the histiocyte society. Med
Pediatr Oncol. 28:342–347. 1997.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Johnson TS, Terrell CE, Millen SH, Katz
JD, Hildeman DA and Jordan MB: Etoposide selectively ablates
activated T cells to control the immunoregulatory disorder
hemophagocytic lymphohistiocytosis. J Immunol. 192:84–91.
2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mahlaoui N, Ouachée-Chardin M, de Saint
Basile G, Neven B, Picard C, Blanche S and Fischer A: Immunotherapy
of familial hemophagocytic lymphohistiocytosis with antithymocyte
globulins: A single-center retrospective report of 38 patients.
Pediatrics. 120:e622–e628. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Latour S and Fischer A: Signaling pathways
involved in the T-cell-mediated immunity against Epstein-Barr
virus: Lessons from genetic diseases. Immunol Rev. 291:174–189.
2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Moss DJ, Burrows SR, Khanna R, Misko IS
and Sculley TB: Immune surveillance against Epstein-Barr virus.
Semin Immunol. 4:97–104. 1992.PubMed/NCBI
|
|
36
|
Kasahara Y and Yachie A: Cell type
specific infection of Epstein-Barr virus (EBV) in EBV-associated
hemophagocytic lymphohistiocytosis and chronic active EBV
infection. Crit Rev Oncol Hematol. 44:283–294. 2002.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Balamuth NJ, Nichols KE, Paessler M and
Teachey DT: Use of rituximab in conjunction with immunosuppressive
chemotherapy as a novel therapy for Epstein Barr virus-associated
hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol.
29:569–573. 2007.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Daver N, McClain K, Allen CE, Parikh SA,
Otrock Z, Rojas-Hernandez C, Blechacz B, Wang S, Minkov M, Jordan
MB, et al: A consensus review on malignancy-associated
hemophagocytic lymphohistiocytosis in adults. Cancer.
123:3229–3240. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Lehmberg K, Nichols KE, Henter JI,
Girschikofsky M, Greenwood T, Jordan M, Kumar A, Minkov M, La Rosée
P and Weitzman S: Study Group on Hemophagocytic Lymphohistiocytosis
Subtypes of the Histiocyte Society. Consensus recommendations for
the diagnosis and management of hemophagocytic lymphohistiocytosis
associated with malignancies. Haematologica. 100:997–1004.
2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Henter JI, Elinder G and Ost A: Diagnostic
guidelines for hemophagocytic lymphohistiocytosis. The FHL study
group of the histiocyte society. Semin Oncol. 18:29–33.
1991.PubMed/NCBI
|
|
41
|
Gurunathan A, Boucher AA, Mark M, Prus KM,
O'Brien MM, Breese EH, Mizukawa BE, Absalon MJ, Nelson AS, Jordan
MB, et al: Limitations of HLH-2004 criteria in distinguishing
malignancy-associated hemophagocytic lymphohistiocytosis. Pediatr
Blood Cancer. 65(e27400)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Gifford CE, Weingartner E, Villanueva J,
Johnson J, Zhang K, Filipovich AH, Bleesing JJ and Marsh RA:
Clinical flow cytometric screening of SAP and XIAP expression
accurately identifies patients with SH2D1A and XIAP/BIRC4
mutations. Cytometry B Clin Cytom. 86:263–271. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Fardet L, Galicier L, Lambotte O, Marzac
C, Aumont C, Chahwan D, Coppo P and Hejblum G: Development and
validation of the HScore, a score for the diagnosis of reactive
hemophagocytic syndrome. Arthritis Rheumatol. 66:2613–2620.
2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Debaugnies F, Mahadeb B, Ferster A,
Meuleman N, Rozen L, Demulder A and Corazza F: Performances of the
H-score for diagnosis of hemophagocytic lymphohistiocytosis in
adult and pediatric patients. Am J Clin Pathol. 145:862–870.
2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Nakashima Y and Koga H: Using a Minimal
Parameter Set for Early Diagnosis of Hemophagocytic
lymphohistiocytosis in non-European children. Am J Case Rep.
23(e934037)2022.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Hines MR, von Bahr Greenwood T, Beutel G,
Beutel K, Hays JA, Horne A, Janka G, Jordan MB, van Laar JAM,
Lachmann G, et al: Consensus-based guidelines for the recognition,
diagnosis, and management of hemophagocytic lymphohistiocytosis in
critically Ill children and adults. Crit Care Med. 50:860–872.
2022.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Koç ZP, Akarsu S, Balci T and Unal K:
PET/CT images of a patient with haemophagocytic
lymphohistiocytosis. BMJ Case Rep.
2012(bcr0320126026)2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Wei A, Lu X, Ma H, Lian H, Yang X, Zhang
L, Wang D, Chen S, Zhang Q, Li Z, et al: 18F-FDG PET/CT
for identifying the potential primary diseases and predicting
prognosis of secondary hemophagocytic lymphohistiocytosis in
children. Contrast Media Mol Imaging. 2022(4849081)2022.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Yang X, Lu X, Liu J, Kan Y, Wang W, Zhang
S, Liu L, Li J and Yang J: Development and validation of
18F-FDG PET/CT-based multivariable clinical prediction
models for the identification of malignancy-associated
hemophagocytic lymphohistiocytosis. Korean J Radiol. 23:466–478.
2022.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Tabata C and Tabata R: Possible prediction
of underlying lymphoma by high sIL-2R/ferritin ratio in
hemophagocytic syndrome. Ann Hematol. 91:63–71. 2012.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Tsuji T, Hirano T, Yamasaki H, Tsuji M and
Tsuda H: A high sIL-2R/ferritin ratio is a useful marker for the
diagnosis of lymphoma-associated hemophagocytic syndrome. Ann
Hematol. 93:821–826. 2014.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Tang Y, Xu X, Song H, Yang S, Shi S, Wei
J, Pan B, Zhao F, Liao C and Luo C: Early diagnostic and prognostic
significance of a specific Th1/Th2 cytokine pattern in children
with haemophagocytic syndrome. Br J Haematol. 143:84–91.
2008.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Chen Y, Wang Z, Luo Z, Zhao N, Yang S and
Tang Y: Comparison of Th1/Th2 cytokine profiles between primary and
secondary haemophagocytic lymphohistiocytosis. Ital J Pediatr.
42(50)2016.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Xu XJ and Tang YM: Dilemmas in diagnosis
and management of hemophagocytic lymphohistiocytosis in children.
World J Pediatr. 16:333–340. 2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Han XC, Ye Q, Zhang WY, Tang YM, Xu XJ and
Zhang T: Cytokine profiles as novel diagnostic markers of
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in
children. J Crit Care. 39:72–77. 2017.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Buatois V, Chatel L, Cons L, Lory S,
Richard F, Guilhot F, Johnson Z, Bracaglia C, De Benedetti F, de
Min C, et al: Use of a mouse model to identify a blood biomarker
for IFNγ activity in pediatric secondary hemophagocytic
lymphohistiocytosis. Transl Res. 180:37–52.e2. 2017.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Prencipe G, Bracaglia C, Caiello I,
Pascarella A, Francalanci P, Pardeo M, Meneghel A, Martini G, Rossi
MN, Insalaco A, et al: The interferon-gamma pathway is selectively
up-regulated in the liver of patients with secondary hemophagocytic
lymphohistiocytosis. PLoS One. 14(e0226043)2019.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Nagasawa M, Yi Z, Imashuku S, Nonoyama S,
Ogawa K, Okumura K and Mizutani S: Soluble TWEAK is markedly
elevated in hemophagocytic lymphohistiocytosis. Am J Hematol.
83:222–225. 2008.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Jenkins RW, Clarke CJ, Lucas JT Jr,
Shabbir M, Wu BX, Simbari F, Mueller J, Hannun YA, Lazarchick J and
Shirai K: Evaluation of the role of secretory sphingomyelinase and
bioactive sphingolipids as biomarkers in hemophagocytic
lymphohistiocytosis. Am J Hematol. 88:E265–E272. 2013.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Chang YH, Lee DS, Jo HS, Cho SI, Yoon HJ,
Shin S, Yoon JH, Kim HY, Hong YJ, Hong SI and Cho HI: Tumor
necrosis factor alpha promoter polymorphism associated with
increased susceptibility to secondary hemophagocytic
lymphohistiocytosis in the Korean population. Cytokine. 36:45–50.
2006.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Yanagimachi M, Goto H, Miyamae T, Kadota
K, Imagawa T, Mori M, Sato H, Yanagisawa R, Kaneko T, Morita S, et
al: Association of IRF5 polymorphisms with susceptibility to
hemophagocytic lymphohistiocytosis in children. J Clin Immunol.
31:946–951. 2011.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Horne A, Zheng C, Lorenz I, Löfstedt M,
Montgomery SM, Janka G, Henter JI and Marion Schneider E: Subtyping
of natural killer cell cytotoxicity deficiencies in haemophagocytic
lymphohistocytosis provides therapeutic guidance. Br J Haematol.
129:658–666. 2005.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Chang TY, Jaffray J, Woda B, Newburger PE
and Usmani GN: Hemophagocytic lymphohistiocytosis with MUNC13-4
gene mutation or reduced natural killer cell function prior to
onset of childhood leukemia. Pediatr Blood Cancer. 56:856–858.
2011.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Emile JF, Abla O, Fraitag S, Horne A,
Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab
O, Allen CE, et al: Revised classification of histiocytoses and
neoplasms of the macrophage-dendritic cell lineages. Blood.
127:2672–2681. 2016.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Mărginean MO, Molnar E and Chinceşan MI:
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in
a small child: A case report. Medicine (Baltimore).
99(e18759)2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Fałkowska A, Prądzyńska K and Drabko K:
Difficult balance between EBV treatment and posttransplant
immunosuppression: A successful transplant in a child with
recurrent Epstein-Barr virus-induced hemophagocytic
lymphohistiocytosis. Transplant Proc. 53:2035–2039. 2021.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Pan H, Feng DN, Song L and Sun LR: Acute
myeloid leukemia following etoposide therapy for EBV-associated
hemophagocytic lymphohistiocytosis: A case report and a brief
review of the literature. BMC Pediatr. 16(116)2016.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Belyea B, Hinson A, Moran C, Hwang E,
Heath J and Barfield R: Spontaneous resolution of Epstein-Barr
virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood
Cancer. 55:754–756. 2010.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Lin MT, Chang HM, Huang CJ, Chen WL, Lin
CY, Lin CY and Chuang SS: Massive expansion of EBV+ monoclonal T
cells with CD5 down regulation in EBV-associated haemophagocytic
lymphohistiocytosis. J Clin Pathol. 60:101–103. 2007.PubMed/NCBI View Article : Google Scholar
|
|
70
|
DomInguez-Pinilla N, Baro-Fernández M and
González-Granado LI: Hemophagocytic lymphohistiocytosis secondary
to Epstein Barr virus and Leishmania co-infection in a toddler. J
Postgrad Med. 61:44–45. 2015.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Gera A, Misra A, Tiwari A, Singh A and
Mehndiratta S: A hungry Histiocyte, altered immunity and myriad of
problems: Diagnostic challenges for Pediatric HLH. Int J Lab
Hematol. 43:1443–1450. 2021.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Oguz MM, Sahin G, Altinel Acoglu E, Polat
E, Yucel H, Oztek Celebi FZ, Unsal H, Akcaboy M, Sari E and Senel
S: Secondary hemophagocytic lymphohistiocytosis in pediatric
patients: A single center experience and factors that influenced
patient prognosis. Pediatr Hematol Oncol. 36:1–16. 2019.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Paul T, Kalra M, Danewa A, Sachdeva P,
Thatikonda KB, Sachdeva D and Sachdeva A: Pediatric hemophagocytic
lymphohistiocytosis-a single center study. Indian Pediatr.
59:283–286. 2022.PubMed/NCBI
|
|
74
|
Imashuku S, Tabata Y, Teramura T and Hibi
S: Treatment strategies for Epstein-Barr virus-associated
hemophagocytic lymphohistiocytosis (EBV-HLH). Leuk Lymphoma.
39:37–49. 2000.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Kawaguchi H, Miyashita T, Herbst H,
Niedobitek G, Asada M, Tsuchida M, Hanada R, Kinoshita A, Sakurai
M, Kobayashi N, et al: Epstein-Barr virus-infected T lymphocytes in
Epstein-Barr virus-associated hemophagocytic syndrome. J Clin
Invest. 92:1444–1450. 1993.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Imashuku S: Clinical features and
treatment strategies of Epstein-Barr virus-associated
hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol.
44:259–272. 2002.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Lohana C, Jhatial MA and Bokhari SWI: A
challenging case of haemophagocytic lymphohistiocytosis (HLH)
secondary to CMV infection in an adolescent with B-acute
lymphoblastic leukemia. J Coll Physicians Surg Pak. 31:1011–1012.
2021.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Pessoa FS, Gonçalves VC and Lacerda EMDCB:
Haemophagocytic lymphohistiocytosis secondary to intrauterine
cytomegalovirus infection. Rev Inst Med Trop Sao Paulo.
63(e15)2021.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Eldem İ, Al-Rahawan MM and Levent F: How
to treat cytomegalovirus-induced hemophagocytic lymphohistiocytosis
in a child with leukemia. J Pediatr Hematol Oncol. 42:313–315.
2020.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Silwedel C, Frieauff E, Thomas W, Liese JG
and Speer CP: Secondary haemophagocytic lymphohistiocytosis
triggered by postnatally acquired cytomegalovirus infection in a
late preterm infant. Infection. 45:355–359. 2017.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Hasan MR, Sundaram MS, Sundararaju S, Tsui
KM, Karim MY, Roscoe D, Imam O, Janahi MA, Thomas E, Dobson S, et
al: Unusual accumulation of a wide array of antimicrobial
resistance mechanisms in a patient with cytomegalovirus-associated
hemophagocytic lymphohistiocytosis: A case report. BMC Infect Dis.
20(237)2020.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Gur G, Cakar N, Uncu N, Ayar G, Basaran O,
Taktak A, Koksoy AY, Acar B and Caycı FS: Hemophagocytic
lymphohistiocytosis secondary to Varicella zoster infection in a
child with Henoch-Schönlein purpura. Pediatr Int. 57:e37–e38.
2015.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Krishnappa A, Munusamy J, Ray S,
Rameshbabu M, Bhatia P, Roy PS, Sundaram V and Kumar P: Neonatal
dengue with HLH: Perks of early diagnosis and management. J Pediatr
Hematol Oncol. 43:e770–e773. 2021.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Agrawal G, Wazir S, Sachdeva A and Kumar
S: Primary dengue infection triggered haemophagocytic
lymphohistiocytosis in a neonate. BMJ Case Rep.
13(e236881)2020.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Krithika MV, Amboiram P, Latha SM, Ninan
B, Suman FR and Scott J: Neonate with haemophagocytic
lymphohistiocytosis secondary to dengue infection: A case report.
Trop Doct. 47:253–255. 2017.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Jasmine YSY, Lee SL and Kan FK: Infection
associated haemophagocytic syndrome in severe dengue infection-a
case series in a district hospital. Med J Malaysia. 72:62–64.
2017.PubMed/NCBI
|
|
87
|
Phuakpet K, Sanpakit K, Vathana N,
Takpradit C, Chokephaibulkit K and Viprakasit V: Hemophagocytic
lymphohistiocytosis following dengue hemorrhagic fever in Hb H/Hb
Constant Spring patient. Pediatr Int. 57:763–765. 2015.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Joshi R, Phatarpekar A, Currimbhoy Z and
Desai M: Haemophagocytic lymphohistiocytosis: A case series from
Mumbai. Ann Trop Paediatr. 31:135–140. 2011.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Nandhakumar D, Loganatha A, Sivasankaran
M, Sivabalan S and Munirathnam D: Hemophagocytic
lymphohistiocytosis in children. Indian J Pediatr. 87:526–531.
2020.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Simon AC, Delhi Kumar CG, Basu D and
Ramesh Kumar R: Hemophagocytic lymphohistiocytosis in children:
Clinical profile and outcome. J Pediatr Hematol Oncol.
42:e281–e285. 2020.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Gayretli Aydin ZG, Yesilbas O, Reis GP and
Guven B: The first pediatric case of hemophagocytic
lymphohistiocytosis secondary to Crimean-Congo haemorrhagic fever
successfully treated with therapeutic plasma exchange accompanying
ribavirin and intravenous immunoglobulin. J Clin Apher. 36:780–784.
2021.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Bıçakçı Z, Tavil B, Tezer H and Olcay L:
Hemophagocytosis in a case with Crimean-Congo hemorrhagic fever and
an overview of possible pathogenesis with current evidence. Turk J
Pediatr. 55:344–348. 2013.PubMed/NCBI
|
|
93
|
Mancao MY, Imran H, Chandra S, Estrada B,
Figarola M, Sosnowski J and Vidal R: Eastern equine encephalitis
virus infection and hemophagocytic lymphohistiocytosis in a
5-month-old infant. Pediatr Infect Dis J. 28:543–545.
2009.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Bay A, Bosnak V, Leblebisatan G, Yavuz S,
Yilmaz F and Hizli S: Hemophagocytic lymphohistiocytosis in 2
pediatric patients secondary to hepatitis A virus infection.
Pediatr Hematol Oncol. 29:211–214. 2012.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Jianguo L, Zhixuan Z, Rong L and Xiaodong
S: Ruxolitinib in alleviating the cytokine storm of hemophagocytic
lymphohistiocytosis. Pediatrics. 146(e20191301)2020.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Chiperi LE, Ionescu AD, Marcu CT,
Itu-Mureşan C and Pantelemon C: Hemophagocytic lymphohistiocytosis
in a child with human immunodeficiency virus infection-a case
report. Rom J Morphol Embryol. 62:279–282. 2021.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Censoplano N, Gorga S, Waldeck K,
Stillwell T, Rabah-Hammad R and Flori H: Neonatal adenovirus
infection complicated by hemophagocytic lymphohistiocytosis
syndrome. Pediatrics. 141 (Suppl 5):S475–S480. 2018.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Otto WR, Behrens EM, Teachey DT, Lamson
DM, Barrett DM, Bassiri H, Lambert MP, Mount S, Petrosa WL, Romberg
N, et al: Human adenovirus 7-associated hemophagocytic
lymphohistiocytosis-like illness: Clinical and virological
characteristics in a cluster of five pediatric cases. Clin Infect
Dis. 73:e1532–e1538. 2021.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Zhang XY, Ye XW, Feng DX, Han J, Li D and
Zhang C: Hemophagocytic lymphohistiocytosis induced by severe
pandemic influenza A (H1N1) 2009 virus infection: A case report.
Case Rep Med. 2011(951910)2011.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Shrestha B, Omran A, Rong P and Wang W:
Report of a fatal pediatric case of hemophagocytic
lymphohistiocytosis associated with pandemic influenza A (H1N1)
infection in 2009. Pediatr Neonatol. 56:189–192. 2015.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Ozdemir H, Çiftçi E, Ince EU, Ertem M,
Ince E and Doğru U: Hemophagocytic lymphohistiocytosis associated
with 2009 pandemic influenza A (H1N1) virus infection. J Pediatr
Hematol Oncol. 33:135–137. 2011.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Tholin B, Hauge MT, Aukrust P, Fehrle L
and Tvedt TH: Hemophagocytic lymphohistiocytosis in a patient with
COVID-19 treated with tocilizumab: A case report. J Med Case Rep.
14(187)2020.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Hakim NN, Chi J, Olazagasti C and Liu JM:
Secondary hemophagocytic lymphohistiocytosis versus cytokine
release syndrome in severe COVID-19 patients. Exp Biol Med
(Maywood). 246:5–9. 2021.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Jose PMM, Paola ZS, Eduardo DG, Arturo
SMMO and Fernando BG: A case of coinfection of a pediatric patient
with acute SARS-COV-2 with MIS-C and severe DENV-2 in Mexico: A
case report. BMC Infect Dis. 21(1072)2021.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Mahdavi M, Hejri GM, Pouraliakbar H,
Shahzadi H, Hesami M and Houshmand G: Cytokine storm after heart
transplantation in COVID-19-related haemophagocytic
lymphohistiocytosis (HLH). ESC Heart Fail. 9:219–223.
2022.PubMed/NCBI View Article : Google Scholar
|
|
106
|
El-Isa HZ, Khader OA, Khader M, Ashour BA,
Azzam MI and Badran EF: Secondary hemophagocytic
lymphohistiocytosis in a neonate with SARS-CoV-2 infection. Am J
Case Rep. 23(e934839)2022.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Mittal J, Kumar P, Goyal JP and Purohit A:
Haemophagocytic lymphohistiocytosis secondary to brucellosis in a
young child. BMJ Case Rep. 14(e240759)2021.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Pekpak E and Sirvan Cetin B: Secondary
hemophagocytic lymphohistocytosis in a child with brucellosis. J
Pediatr Hematol Oncol. 39:e501–e503. 2017.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Yaman Y, Gözmen S, Özkaya AK, Oymak Y, Apa
H, Vergin C and Devrim İ: Secondary hemophagocytic
lymphohistiocytosis in children with brucellosis: Report of three
cases. J Infect Dev Ctries. 9:1172–1176. 2015.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Banday AZ, Mehta R, Vignesh P, Kanaujia R,
Durgadevi S, Angrup A, Kumar N, Ray P and Suri D: Case Report:
Ceftriaxone-resistant invasive Salmonella enteritidis
infection with secondary hemophagocytic lymphohistiocytosis: A
contrast with enteric fever. Am J Trop Med Hyg. 103:2515–2517.
2020.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Maheshwari P, Chhabra R and Yadav P:
Perinatal tuberculosis associated hemophagocytic
lymphohistiocytosis. Indian J Pediatr. 79:1228–1229.
2012.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Choi YB and Yi DY: Fatal case of
hemophagocytic lymphohistiocytosis associated with group B
streptococcus sepsis: A case report. Medicine (Baltimore).
97(e12210)2018.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Liu SS, Wang Y, Xue L, Ma C and Li CH:
Hemophagocytic lymphohistiocytosis due to Streptococcus suis
in a 12-year-old girl: A case report. Medicine (Baltimore).
98(e15136)2019.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Sahu SK, Behera JR and Yadav SK: Scrub
typhus with secondary hemophagocytic lymphohistiocytosis in a
3-month-old child from a tertiary care hospital of Odisha. Indian J
Public Health. 65:85–86. 2021.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Han DK, Baek HJ, Shin MG, Kim JW, Kook H
and Hwang TJ: Scrub typhus-associated severe hemophagocytic
lymphohistiocytosis with encephalomyelitis leading to permanent
sequelae: A case report and review of the literature. J Pediatr
Hematol Oncol. 34:531–533. 2012.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Agrwal S, Dabas A, Mantan M and Yadav S:
Hemophagocytic lymphohistiocytosis with neurological manifestations
in an infant with scrub typhus: A rare fatal occurrence. Trop Doct.
49:52–53. 2019.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Pazhaniyandi S, Lenin R and Sivathanu S:
Hemophagocytic lymphohistiocytosis with a leukemoid reaction in an
infant with scrub typhus. J Infect Public Health. 8:626–629.
2015.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Otrock ZK, Gonzalez MD and Eby CS:
Ehrlichia-induced hemophagocytic lymphohistiocytosis: A case series
and review of literature. Blood Cells Mol Dis. 55:191–193.
2015.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Cheng A, Williams F, Fortenberry J,
Preissig C, Salinas S and Kamat P: Use of extracorporeal support in
hemophagocytic lymphohistiocytosis secondary to ehrlichiosis.
Pediatrics. 138(e20154176)2016.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Burns S, Saylors R and Mian A:
Hemophagocytic lymphohistiocytosis secondary to Ehrlichia
chaffeensis infection: A case report. J Pediatr Hematol Oncol.
32:e142–143. 2010.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Singh NS, Pagano AL, Hays AJ, Kats A, Dahl
SM, Warady BA, Beins NT and Yin DE: Ehrlichia-induced
hemophagocytic lymphohistiocytosis in a pediatric kidney transplant
recipient. Pediatr Transplant. 26(e14134)2022.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Cabler SS, Hogan PG, Fritz SA, Bednarski
JJ and Hunstad DA: Incidence and treatment of hemophagocytic
lymphohistiocytosis in hospitalized children with Ehrlichia
infection. Pediatr Blood Cancer. 67(e28436)2020.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Tsuge M, Miyamoto M, Miyawaki R, Kondo Y
and Tsukahara H: Hemophagocytic lymphohistiocytosis complicating
invasive pneumococcal disease: A pediatric case report. BMC
Pediatr. 20(15)2020.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Poudel A, Lew J, Slayton W and
Dharnidharka VR: Bartonella henselae infection inducing
hemophagocytic lymphohistiocytosis in a kidney transplant
recipient. Pediatr Transplant. 18:E83–E87. 2014.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Edner J, Rudd E, Zheng C, Dahlander A,
Eksborg S, Schneider EM, Edner A and Henter JI: Severe
bacteria-associated hemophagocytic lymphohistiocytosis in an
extremely premature infant. Acta Paediatr. 96:1703–1706.
2007.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Karapinar DY, Karadaş N, Yazici P, Polat
SH and Karapinar B: Trichosporon asahii, sepsis, and
secondary hemophagocytic lymphohistiocytosis in children with
hematologic malignancy. Pediatr Hematol Oncol. 31:282–284.
2014.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Guo F, Kang L and Xu M: A case of
pediatric visceral leishmaniasis-related hemophagocytic
lymphohistiocytosis diagnosed by mNGS. Int J Infect Dis. 97:27–29.
2020.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Guo X, Chen N, Wang TY, Zhou YC, Li Q and
Gao J: Visceral leishmaniasis associated hemophagocytic
lymphohistiocytosis: Report of four childhood cases. Zhonghua Er Ke
Za Zhi. 49:550–553. 2011.PubMed/NCBI(In Chinese).
|
|
129
|
Bouguila J, Chabchoub I, Moncef Y, Mlika
A, Saghrouni F, Boughamoura L and Essoussi AS: Treatment of severe
hemophagocytic syndrome associated with visceral leishmaniasis.
Arch Pediatr. 17:1566–1570. 2010.PubMed/NCBI View Article : Google Scholar : (In French).
|
|
130
|
Castberg FC, Poulsen A, Petersen BL and
Lausen B: Visceral leishmaniasis in two children after vacation in
Southern Europe. Ugeskr Laeger. 175:2193–2194. 2013.PubMed/NCBI(In Danish).
|
|
131
|
Rajagopala S, Dutta U, Chandra KSP, Bhatia
P, Varma N and Kochhar R: Visceral leishmaniasis associated
hemophagocytic lymphohistiocytosis-case report and systematic
review. J Infect. 56:381–388. 2008.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Ay Y, Yildiz B, Unver H, Karapinar DY and
Vardar F: Hemophagocytic lymphohistiocytosis associated with H1N1
virus infection and visceral leishmaniasis in a 4.5-month-old
infant. Rev Soc Bras Med Trop. 45:407–409. 2012.PubMed/NCBI
|
|
133
|
Mottaghipisheh H, Kalantar K, Amanati A,
Shokripour M, Shahriari M, Zekavat OR, Zareifar S, Karimi M,
Haghpanah S and Bordbar M: Comparison of the clinical features and
outcome of children with hemophagocytic lymphohistiocytosis (HLH)
secondary to visceral leishmaniasis and primary HLH: A
single-center study. BMC Infect Dis. 21(732)2021.PubMed/NCBI View Article : Google Scholar
|
|
134
|
de Carvalho FHG, Lula JF, Teles LF,
Caldeira AP and de Carvalho SFG: Hemophagocytic lymphohistiocytosis
secondary to visceral leishmaniasis in an endemic area in the north
of Minas Gerais, Brazil. Rev Soc Bras Med Trop.
53(e20190491)2020.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Shi Q, Huang M, Li X, Zheng X, Wang F, Zou
Y, Wang L and Jia J: Clinical and laboratory characteristics of
hemophagocytic lymphohistiocytosis induced by Leishmania infantum
infection. PLoS Negl Trop Dis. 15(e0009944)2021.PubMed/NCBI View Article : Google Scholar
|
|
136
|
Srivatsav S, Mahalingam S, Ramineni P and
Manya S: Dengue and Plasmodium falciparum coinfection with
secondary hemophagocytic lymphohistiocytosis in a 3-year-old boy: A
clinical conundrum. J Pediatr Hematol Oncol. 44:e253–e254.
2022.PubMed/NCBI View Article : Google Scholar
|
|
137
|
Padhi S, Varghese RGB, Ramdas A,
Phansalkar MD and Sarangi R: Hemophagocytic lymphohistiocytosis:
Critical reappraisal of a potentially under-recognized condition.
Front Med. 7:492–498. 2013.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Lehmberg K, Sprekels B, Nichols KE,
Woessmann W, Müller I, Suttorp M, Bernig T, Beutel K, Bode SF,
Kentouche K, et al: Malignancy-associated haemophagocytic
lymphohistiocytosis in children and adolescents. Br J Haematol.
170:539–549. 2015.PubMed/NCBI View Article : Google Scholar
|
|
139
|
O'Brien MM, Lee-Kim Y, George TI, McClain
KL, Twist CJ and Jeng M: Precursor B-cell acute lymphoblastic
leukemia presenting with hemophagocytic lymphohistiocytosis.
Pediatr Blood Cancer. 50:381–383. 2008.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Celkan T, Berrak S, Kazanci E, Ozyürek E,
Unal S, Uçar C, Yilmaz S and Gürgey A: Malignancy-associated
hemophagocytic lymphohistiocytosis in pediatric cases: A
multicenter study from Turkey. Turk J Pediatr. 51:207–213.
2009.PubMed/NCBI
|
|
141
|
Strenger V, Merth G, Lackner H, Aberle SW,
Kessler HH, Seidel MG, Schwinger W, Sperl D, Sovinz P, Karastaneva
A, et al: Malignancy and chemotherapy induced haemophagocytic
lymphohistiocytosis in children and adolescents-a single centre
experience of 20 years. Ann Hematol. 97:989–998. 2018.PubMed/NCBI View Article : Google Scholar
|
|
142
|
Chellapandian D, Hines MR, Zhang R, Jeng
M, van den Bos C, Santa-María López V, Lehmberg K, Sieni E, Wang Y,
Nakano T, et al: A multicenter study of patients with multisystem
Langerhans cell histiocytosis who develop secondary hemophagocytic
lymphohistiocytosis. Cancer. 125:963–971. 2019.PubMed/NCBI View Article : Google Scholar
|
|
143
|
Chinn IK, Eckstein OS, Peckham-Gregory EC,
Goldberg BR, Forbes LR, Nicholas SK, Mace EM, Vogel TP, Abhyankar
HA, Diaz MI, et al: Genetic and mechanistic diversity in pediatric
hemophagocytic lymphohistiocytosis. Blood. 132:89–100.
2018.PubMed/NCBI View Article : Google Scholar
|
|
144
|
Cader FZ, Colmenero I and Mussai F:
Hemophagocytic lymphohistiocytosis associated with 2 cases of
pediatric lymphocyte-depleted classic hodgkin lymphoma. J Pediatr
Hematol Oncol. 41:e341–e345. 2019.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Huang Z, Jia Y, Zuo Y, Wu J, Lu A and
Zhang L: Malignancy-associated hemophagocytic lymphohistiocytosis
in children: A 10-year experience of a single pediatric hematology
center. Hematology. 25:389–399. 2020.PubMed/NCBI View Article : Google Scholar
|
|
146
|
Sakamoto K, Osumi T, Yoshimura S, Shimizu
S, Kato M, Tomizawa D, Fukuda A, Sakamoto S, Nakano N, Yoshioka T,
et al: Living-donor liver transplantation providing an adequate
chemotherapy for a pediatric patient with anaplastic large cell
lymphoma complicated with liver failure due to the aggravation of
biliary hepatopathy by secondary hemophagocytic
lymphohistiocytosis. Int J Hematol. 112:900–905. 2020.PubMed/NCBI View Article : Google Scholar
|
|
147
|
Teshigawara S, Katada Y, Maeda Y,
Yoshimura M, Kudo-Tanaka E, Tsuji S, Harada Y, Matsushita M,
Ohshima S, Watanabe K, et al: Hemophagocytic lymphohistiocytosis
with leukoencephalopathy in a patient with dermatomyositis
accompanied with peripheral T-cell lymphoma: A case report. J Med
Case Rep. 10(212)2016.PubMed/NCBI View Article : Google Scholar
|
|
148
|
Sinno MG, Rosen D and Wittler R:
Concomitant presentation of hemophagocytic lymphohistiocytosis and
posttransplant lymphoproliferative disease-like lymphoma in a
mildly immunosuppressed leukemia patient: An unusual association.
Pediatr Blood Cancer. 63:1474–1476. 2016.PubMed/NCBI View Article : Google Scholar
|
|
149
|
McCall CM, Mudali S, Arceci RJ, Small D,
Fuller S, Gocke CD, Vuica-Ross M, Burns KH, Borowitz MJ and
Duffield AS: Flow cytometric findings in hemophagocytic
lymphohistiocytosis. Am J Clin Pathol. 137:786–794. 2012.PubMed/NCBI View Article : Google Scholar
|
|
150
|
Zheng F, Jia Y, Zhang L and Qin J:
Hemophagocytic lymphohistiocytosis secondary to juvenile
myelomonocytic leukemia: A case report and review of the
literature. J Pediatr Hematol Oncol. 44:e580–e584. 2022.PubMed/NCBI View Article : Google Scholar
|
|
151
|
Farias MG, Freitas PAC, Spagnol F, Souza
MV, Alegretti AP, Riegel M, Taniguchi ANR and Daudt LE:
Hemophagocytosis by blasts in a child with acute monocytic leukemia
after chemotherapy. Rev Paul Pediatr. 39(e2019290)2021.PubMed/NCBI View Article : Google Scholar : (In Portuguese,
English).
|
|
152
|
Dokmanovic L, Krstovski N, Jankovic S and
Janic D: Hemophagocytic lymphohistiocytosis arising in a child with
Langerhans cell histiocytosis. Turk J Pediatr. 56:452–457.
2014.PubMed/NCBI
|
|
153
|
Murphy EP, Mo J and Yoon JM: Secondary
hemophagocytic lymphohistiocytosis in a patient with favorable
histology wilms tumor. J Pediatr Hematol Oncol. 37:e494–e496.
2015.PubMed/NCBI View Article : Google Scholar
|
|
154
|
Nascimento FA, Nery J, Trennepohl J and
Pianovski MAD: Hemophagocytic lymphohistiocytosis after initiation
of chemotherapy for bilateral adrenal neuroblastoma. J Pediatr
Hematol Oncol. 38:e13–e15. 2016.PubMed/NCBI View Article : Google Scholar
|
|
155
|
Tang X, Guo X, Gao J, Sun JJ and Wan Z:
Hemophagocytic lymphohistiocytosis in langerhans cell
histiocytosis: A case series and literature review. J Pediatr
Hematol Oncol. 44:e20–e25. 2022.PubMed/NCBI View Article : Google Scholar
|
|
156
|
Devecioglu O, Anak S, Atay D, Aktan P,
Devecioglu E, Ozalp B and Saribeyoglu E: Pediatric acute
lymphoblastic leukemia complicated by secondary hemophagocytic
lymphohistiocytosis. Pediatr Blood Cancer. 53:491–492.
2009.PubMed/NCBI View Article : Google Scholar
|
|
157
|
Henderson LA and Cron RQ: Macrophage
activation syndrome and secondary hemophagocytic
lymphohistiocytosis in childhood inflammatory disorders: Diagnosis
and management. Paediatr Drugs. 22:29–44. 2020.PubMed/NCBI View Article : Google Scholar
|
|
158
|
Sandler RD, Tattersall RS, Schoemans H,
Greco R, Badoglio M, Labopin M, Alexander T, Kirgizov K, Rovira M,
Saif M, et al: Diagnosis and management of secondary HLH/MAS
following HSCT and CAR-T cell therapy in adults; A review of the
literature and a survey of practice within EBMT centres on behalf
of the autoimmune diseases working party (ADWP) and transplant
complications working party (TCWP). Front Immunol.
11(524)2020.PubMed/NCBI View Article : Google Scholar
|
|
159
|
Teachey DT, Lacey SF, Shaw PA, Melenhorst
JJ, Maude SL, Frey N, Pequignot E, Gonzalez VE, Chen F, Finklestein
J, et al: Identification of predictive biomarkers for cytokine
release syndrome after chimeric antigen receptor T-cell therapy for
acute lymphoblastic leukemia. Cancer Discov. 6:664–679.
2016.PubMed/NCBI View Article : Google Scholar
|
|
160
|
Neelapu SS, Tummala S, Kebriaei P, Wierda
W, Gutierrez C, Locke FL, Komanduri KV, Lin Y, Jain N, Daver N, et
al: Chimeric antigen receptor T-cell therapy-assessment and
management of toxicities. Nat Rev Clin Oncol. 15:47–62.
2018.PubMed/NCBI View Article : Google Scholar
|
|
161
|
Lichtenstein DA, Schischlik F, Shao L,
Steinberg SM, Yates B, Wang HW, Wang Y, Inglefield J, Dulau-Florea
A, Ceppi F, et al: Characterization of HLH-like manifestations as a
CRS variant in patients receiving CD22 CAR T cells. Blood.
138:2469–2484. 2021.PubMed/NCBI View Article : Google Scholar
|
|
162
|
Hines MR, Keenan C, Maron Alfaro G, Cheng
C, Zhou Y, Sharma A, Hurley C, Nichols KE, Gottschalk S, Triplett
BM and Talleur AC: Hemophagocytic lymphohistiocytosis-like toxicity
(carHLH) after CD19-specific CAR T-cell therapy. Br J Haematol.
194:701–707. 2021.PubMed/NCBI View Article : Google Scholar
|
|
163
|
Maude SL, Laetsch TW, Buechner J, Rives S,
Boyer M, Bittencourt H, Bader P, Verneris MR, Stefanski HE, Myers
GD, et al: Tisagenlecleucel in children and young adults with
B-cell lymphoblastic leukemia. N Engl J Med. 378:439–448.
2018.PubMed/NCBI View Article : Google Scholar
|
|
164
|
Xu XJ and Tang YM: Cytokine release
syndrome in cancer immunotherapy with chimeric antigen receptor
engineered T cells. Cancer Lett. 343:172–178. 2014.PubMed/NCBI View Article : Google Scholar
|
|
165
|
Singh N, Hofmann TJ, Gershenson Z, Levine
BL, Grupp SA, Teachey DT and Barrett DM: Monocyte lineage-derived
IL-6 does not affect chimeric antigen receptor T-cell function.
Cytotherapy. 19:867–880. 2017.PubMed/NCBI View Article : Google Scholar
|
|
166
|
Giavridis T, van der Stegen SJC, Eyquem J,
Hamieh M, Piersigilli A and Sadelain M: CAR T cell-induced cytokine
release syndrome is mediated by macrophages and abated by IL-1
blockade. Nat Med. 24:731–738. 2018.PubMed/NCBI View Article : Google Scholar
|
|
167
|
Norelli M, Camisa B, Barbiera G, Falcone
L, Purevdorj A, Genua M, Sanvito F, Ponzoni M, Doglioni C,
Cristofori P, et al: Monocyte-derived IL-1 and IL-6 are
differentially required for cytokine-release syndrome and
neurotoxicity due to CAR T cells. Nat Med. 24:739–748.
2018.PubMed/NCBI View Article : Google Scholar
|
|
168
|
Liu Y, Fang Y, Chen X, Wang Z, Liang X,
Zhang T, Liu M, Zhou N, Lv J, Tang K, et al: Gasdermin E-mediated
target cell pyroptosis by CAR T cells triggers cytokine release
syndrome. Sci Immunol. 5(eaax7969)2020.PubMed/NCBI View Article : Google Scholar
|
|
169
|
Teachey DT, Rheingold SR, Maude SL,
Zugmaier G, Barrett DM, Seif AE, Nichols KE, Suppa EK, Kalos M,
Berg RA, et al: Cytokine release syndrome after blinatumomab
treatment related to abnormal macrophage activation and ameliorated
with cytokine-directed therapy. Blood. 121:5154–5157.
2013.PubMed/NCBI View Article : Google Scholar
|
|
170
|
Winkler U, Jensen M, Manzke O, Schulz H,
Diehl V and Engert A: Cytokine-release syndrome in patients with
B-cell chronic lymphocytic leukemia and high lymphocyte counts
after treatment with an anti-CD20 monoclonal antibody (rituximab,
IDEC-C2B8). Blood. 94:2217–2224. 1999.PubMed/NCBI
|
|
171
|
Asano T, Kogawa K, Morimoto A, Ishida Y,
Suzuki N, Ohga S, Kudo K, Ohta S, Wakiguchi H, Tabuchi K, et al:
Hemophagocytic lymphohistiocytosis after hematopoietic stem cell
transplantation in children: A nationwide survey in Japan. Pediatr
Blood Cancer. 59:110–114. 2012.PubMed/NCBI View Article : Google Scholar
|
|
172
|
Noguchi M and Inagaki J: Hemophagocytic
lymphohistiocytosis and graft failure following unrelated umbilical
cord blood transplantation in children. J Pediatr Hematol Oncol.
42:e440–e444. 2020.PubMed/NCBI View Article : Google Scholar
|
|
173
|
Jarchin L, Chu J, Januska M, Merola P and
Arnon R: Autoimmune hemolytic anemia: An unusual presentation of
hemophagocytic lymphohistiocytosis in a pediatric post-liver
transplant patient. Pediatr Transplant. 22(e13281)2018.PubMed/NCBI View Article : Google Scholar
|
|
174
|
Nakajima K, Hiejima E, Nihira H, Kato K,
Honda Y, Izawa K, Kawabata N, Kato I, Ogawa E, Sonoda M, et al:
Case report: A case of Epstein-Barr virus-associated acute liver
failure requiring hematopoietic cell transplantation after emergent
liver transplantation. Front Immunol. 13(825806)2022.PubMed/NCBI View Article : Google Scholar
|
|
175
|
Jha B, Mohan N, Gajendra S, Sachdev R,
Goel S, Sahni T, Raina V and Soin A: Prompt diagnosis and
management of Epstein-Barr virus-associated post-transplant
lymphoproliferative disorder and hemophagocytosis: A dreaded
complication in a post-liver transplant child. Pediatr Transplant.
19:E177–E180. 2015.PubMed/NCBI View Article : Google Scholar
|
|
176
|
Matsuda K, Toyama K, Toya T, Ikemura M,
Nakamura F and Kurokawa M: Reactivation of hemophagocytic
lymphohistiocytosis triggered by antithymocyte globulin. Intern
Med. 57:583–586. 2018.PubMed/NCBI View Article : Google Scholar
|
|
177
|
Ali S, AlThubaiti S, Renzi S, Krueger J,
Chiang KY, Naqvi A, Schechter T, Punnett A and Ali M:
Hemophagocytic lymphohistiocytosis is a sign of poor outcome in
pediatric Epstein-Barr virus-associated post-transplant
lymphoproliferative disease after allogeneic hematopoietic stem
cell transplantation. Pediatr Transplant. 23(e13319)2019.PubMed/NCBI View Article : Google Scholar
|
|
178
|
Park M, Yun YJ, Woo SI, Lee JW, Chung NG
and Cho B: Rotavirus-associated hemophagocytic lymphohistiocytosis
(HLH) after hematopoietic stem cell transplantation for familial
HLH. Pediatr Int. 57:e77–e80. 2015.PubMed/NCBI View Article : Google Scholar
|
|
179
|
Salvador C, Meister B, Larcher H,
Crazzolara R and Kropshofer G: Hemophagocytic lymphohistiocytosis
after allogeneic bone marrow transplantation during chronic
norovirus infection. Hematol Oncol. 32:102–106. 2014.PubMed/NCBI View Article : Google Scholar
|
|
180
|
Hattori N, Sato M, Uesugi Y, Nakata A,
Sasaki Y, Shimada S, Watanuki M, Fujiwara S, Kawaguchi Y, Arai N,
et al: Characteristics and predictors of post-transplant-associated
hemophagocytic lymphohistiocytosis in adults. Int J Hematol.
113:693–702. 2021.PubMed/NCBI View Article : Google Scholar
|
|
181
|
Stefanou C, Tzortzi C, Georgiou F and
Timiliotou C: Combining an antiviral with rituximab in EBV-related
haemophagocytic lymphohistiocytosis led to rapid viral clearance;
and a comprehensive review. BMJ Case Rep.
2016(bcr2016216488)2016.PubMed/NCBI View Article : Google Scholar
|
|
182
|
Farias-Moeller R, LaFrance-Corey R,
Bartolini L, Wells EM, Baker M, Doslea A, Suslovic W, Greenberg J,
Carpenter JL and Howe CL: Fueling the FIRES: Hemophagocytic
lymphohistiocytosis in febrile infection-related epilepsy syndrome.
Epilepsia. 59:1753–1763. 2018.PubMed/NCBI View Article : Google Scholar
|
|
183
|
Dandoy C and Grimley M: Secondary
hemophagocytic lymphohistiocytosis (HLH) from a presumed brown
recluse spider bite. J Clin Immunol. 34:544–547. 2014.PubMed/NCBI View Article : Google Scholar
|
|
184
|
Alabbas F, Elyamany G, Alanzi T, Ali TB,
Albatniji F and Alfaraidi H: Wolman's disease presenting with
secondary hemophagocytic lymphohistiocytosis: A case report from
Saudi Arabia and literature review. BMC Pediatr.
21(72)2021.PubMed/NCBI View Article : Google Scholar
|
|
185
|
Schüller S, Attarbaschi A, Berger A,
Hutter C, Klebermass-Schrehof K and Steiner M: Hemophagocytic
lymphohistiocytosis triggered by Gaucher disease in a preterm
neonate. Pediatr Hematol Oncol. 33:462–467. 2016.PubMed/NCBI View Article : Google Scholar
|
|
186
|
Gokce M, Unal O, Hismi B, Gumruk F, Coskun
T, Balta G, Unal S, Cetin M, Kalkanoglu-Sivri HS, Dursun A and
Tokatlı A: Secondary hemophagocytosis in 3 patients with organic
acidemia involving propionate metabolism. Pediatr Hematol Oncol.
29:92–98. 2012.PubMed/NCBI View Article : Google Scholar
|
|
187
|
Erdol S, Ture M, Baytan B, Yakut T and
Saglam H: An unusual case of LCHAD deficiency presenting with a
clinical picture of hemophagocytic lymphohistiocytosis: Secondary
HLH or coincidence? J Pediatr Hematol Oncol. 38:661–662.
2016.PubMed/NCBI View Article : Google Scholar
|
|
188
|
Düzenli Kar Y, Özdemir ZC, Kiral E, Kiliç
Yildirim G, Dinleyici EÇ and Bör Ö: Hemophagocytic
lymphohystiocytosis associated with type Ia glycogen storage
disease. J Pediatr Hematol Oncol. 41:e260–e262. 2019.PubMed/NCBI View Article : Google Scholar
|
|
189
|
Santos Silva E, Klaudel-Dreszler M, Bakuła
A, Oliva T, Sousa T, Fernandes PC, Tylki-Szymańska A, Kamenets E,
Martins E and Socha P: Early onset lysosomal acid lipase deficiency
presenting as secondary hemophagocytic lymphohistiocytosis: Two
infants treated with sebelipase alfa. Clin Res Hepatol
Gastroenterol. 42:e77–e82. 2018.PubMed/NCBI View Article : Google Scholar
|
|
190
|
Faraguna MC, Musto F, Crescitelli V,
Iascone M, Spaccini L, Tonduti D, Fedeli T, Kullmann G, Canonico F,
Cattoni A, et al: Mucopolysaccharidosis-plus syndrome, a rapidly
progressive disease: Favorable impact of a very prolonged steroid
treatment on the clinical course in a child. Genes (Basel).
13(442)2022.PubMed/NCBI View Article : Google Scholar
|
|
191
|
Merli P, Quintarelli C, Strocchio L and
Locatelli F: The role of interferon-gamma and its signaling pathway
in pediatric hematological disorders. Pediatr Blood Cancer.
68(e28900)2021.PubMed/NCBI View Article : Google Scholar
|
|
192
|
George MR: Hemophagocytic
lymphohistiocytosis: Review of etiologies and management. J Blood
Med. 5:69–86. 2014.PubMed/NCBI View Article : Google Scholar
|
|
193
|
Henter JI, Samuelsson-Horne A, Aricò M,
Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D,
Ladisch S, et al: Treatment of hemophagocytic lymphohistiocytosis
with HLH-94 immunochemotherapy and bone marrow transplantation.
Blood. 100:2367–2373. 2002.PubMed/NCBI View Article : Google Scholar
|
|
194
|
Jordan M, Prof FL, Allen C, De Benedetti
F, Grom AA, Ballabio M, Ferlin WG and De Min C: A novel targeted
approach to the treatment of hemophagocytic lymphohistiocytosis
(HLH) with an anti-interferon gamma (IFNγ) monoclonal antibody
(mAb), NI-0501: First results from a pilot phase 2 study in
children with primary HLH. Blood. 126:LBA–3. 2015.
|
|
195
|
Locatelli F, Jordan MB, Allen C, Cesaro S,
Rizzari C, Rao A, Degar B, Garrington TP, Sevilla J, Putti MC, et
al: Emapalumab in children with primary hemophagocytic
lymphohistiocytosis. N Engl J Med. 382:1811–1822. 2020.PubMed/NCBI View Article : Google Scholar
|
|
196
|
Marsh RA, Allen CE, McClain KL, Weinstein
JL, Kanter J, Skiles J, Lee ND, Khan SP, Lawrence J, Mo JQ, et al:
Salvage therapy of refractory hemophagocytic lymphohistiocytosis
with alemtuzumab. Pediatr Blood Cancer. 60:101–109. 2013.PubMed/NCBI View Article : Google Scholar
|
|
197
|
Das R, Guan P, Sprague L, Verbist K,
Tedrick P, An QA, Cheng C, Kurachi M, Levine R, Wherry EJ, et al:
Janus kinase inhibition lessens inflammation and ameliorates
disease in murine models of hemophagocytic lymphohistiocytosis.
Blood. 127:1666–1675. 2016.PubMed/NCBI View Article : Google Scholar
|
|
198
|
De Benedetti F, Brunner HI, Ruperto N,
Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R,
Woo P, et al: Randomized trial of tocilizumab in systemic juvenile
idiopathic arthritis. N Engl J Med. 367:2385–2395. 2012.PubMed/NCBI View Article : Google Scholar
|
|
199
|
Huang P, Huang C, Xu H, Lu J, Tian R, Wang
Z and Chen Y: Early use of blood purification in severe
Epstein-Barr virus-associated hemophagocytic syndrome. Pediatrics.
145(e20193197)2020.PubMed/NCBI View Article : Google Scholar
|
|
200
|
Bottari G, Murciano M, Merli P, Bracaglia
C, Guzzo I, Stoppa F, Pardeo M, Nunziata J, Bufalo FD, Genuini L,
et al: Hemoperfusion with cytosorb to manage multiorgan dysfunction
in the spectrum of hemophagocytic lymphohistiocytosis syndrome in
critically Ill children. Blood Purif. 51:417–424. 2022.PubMed/NCBI View Article : Google Scholar
|
|
201
|
Matsumoto Y, Naniwa D, Banno S and Sugiura
Y: The efficacy of therapeutic plasmapheresis for the treatment of
fatal hemophagocytic syndrome: Two case reports. Ther Apher.
2:300–304. 1998.PubMed/NCBI View Article : Google Scholar
|
|
202
|
Demirkol D, Yildizdas D, Bayrakci B,
Karapinar B, Kendirli T, Koroglu TF, Dursun O, Erkek N, Gedik H,
Citak A, et al: Hyperferritinemia in the critically ill child with
secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ
dysfunction syndrome/macrophage activation syndrome: What is the
treatment? Crit Care. 16(R52)2012.PubMed/NCBI View Article : Google Scholar
|
|
203
|
La Rosée P, Horne A, Hines M, von Bahr
Greenwood T, Machowicz R, Berliner N, Birndt S, Gil-Herrera J,
Girschikofsky M, Jordan MB, et al: Recommendations for the
management of hemophagocytic lymphohistiocytosis in adults. Blood.
133:2465–2477. 2019.PubMed/NCBI View Article : Google Scholar
|
|
204
|
Yan WL, Yang SL, Zhao FY and Xu XJ:
Ruxolitinib is an alternative to etoposide for patient with
hemophagocytic lymphohistiocytosis complicated by acute renal
injury: A case report. J Oncol Pharm Pract. 28:222–227.
2022.PubMed/NCBI View Article : Google Scholar
|
|
205
|
Broglie L, Pommert L, Rao S, Thakar M,
Phelan R, Margolis D and Talano J: Ruxolitinib for treatment of
refractory hemophagocytic lymphohistiocytosis. Blood Adv.
1:1533–1536. 2017.PubMed/NCBI View Article : Google Scholar
|
|
206
|
Cançado GGL, Freitas GG, Faria FHF, de
Macedo AV and Nobre V: Hemophagocytic lymphohistiocytosis
associated with visceral leishmaniasis in late adulthood. Am J Trop
Med Hyg. 88:575–577. 2013.PubMed/NCBI View Article : Google Scholar
|
|
207
|
Imashuku S, Kuriyama K, Teramura T, Ishii
E, Kinugawa N, Kato M, Sako M and Hibi S: Requirement for etoposide
in the treatment of Epstein-Barr virus-associated hemophagocytic
lymphohistiocytosis. J Clin Oncol. 19:2665–2673. 2001.PubMed/NCBI View Article : Google Scholar
|
|
208
|
Huang Z and Xie J: Ruxolitinib in
conjunction with the HLH-94 protocol for Epstein-Barr virus-related
hemophagocytic lymphohistiocytosis in the intensive care unit: A
case report. Medicine (Baltimore). 100(e25188)2021.PubMed/NCBI View Article : Google Scholar
|
|
209
|
Zhao Y, Li Z, Zhang L, Lian H, Ma H, Wang
D, Zhao X, Zhang Q, Wang T and Zhang R: L-DEP regimen salvage
therapy for paediatric patients with refractory Epstein-Barr
virus-associated haemophagocytic lymphohistiocytosis. Br J
Haematol. 191:453–459. 2020.PubMed/NCBI View Article : Google Scholar
|
|
210
|
Shiraishi A, Ohga S, Doi T, Ishimura M,
Takimoto T, Takada H, Miyamoto T, Abe Y and Hara T: Treatment
choice of immunotherapy or further chemotherapy for Epstein-Barr
virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood
Cancer. 59:265–270. 2012.PubMed/NCBI View Article : Google Scholar
|
|
211
|
Lackner H, Seidel MG, Strenger V, Sovinz
P, Schwinger W, Benesch M, Sperl D and Urban C: Hemophagocytic
syndrome in children with acute monoblastic leukemia-another cause
of fever of unknown origin. Support Care Cancer. 21:3519–3523.
2013.PubMed/NCBI View Article : Google Scholar
|
|
212
|
Chi MS, Chang YC and Chi KH: In reply to
roos et al. Int J Radiat Oncol Biol Phys. 101(1003)2018.
|
|
213
|
Han L, Li L, Wu J, Li X, Zhang L, Wang X,
Fu X, Ma W, Sun Z, Zhang X, et al: Clinical features and treatment
of natural killer/T cell lymphoma associated with hemophagocytic
syndrome: comparison with other T cell lymphoma associated with
hemophagocytic syndrome. Leuk Lymphoma. 55:2048–2055.
2014.PubMed/NCBI View Article : Google Scholar
|
|
214
|
Eloseily EM, Weiser P, Crayne CB, Haines
H, Mannion ML, Stoll ML, Beukelman T, Atkinson TP and Cron RQ:
Benefit of anakinra in treating pediatric secondary hemophagocytic
lymphohistiocytosis. Arthritis Rheumatol. 72:326–334.
2020.PubMed/NCBI View Article : Google Scholar
|
|
215
|
Bami S, Vagrecha A, Soberman D, Badawi M,
Cannone D, Lipton JM, Cron RQ and Levy CF: The use of anakinra in
the treatment of secondary hemophagocytic lymphohistiocytosis.
Pediatr Blood Cancer. 67(e28581)2020.PubMed/NCBI View Article : Google Scholar
|
|
216
|
Bagri NK, Gupta L, Sen ES and Ramanan AV:
Macrophage activation syndrome in children: Diagnosis and
management. Indian Pediatr. 58:1155–1161. 2021.PubMed/NCBI View Article : Google Scholar
|
|
217
|
Ravelli A, Minoia F, Davì S, Horne A,
Bovis F, Pistorio A, Aricò M, Avcin T, Behrens EM, De Benedetti F,
et al: 2016 Classification criteria for macrophage activation
syndrome complicating systemic juvenile idiopathic arthritis: A
European league against rheumatism/American college of
rheumatology/paediatric rheumatology international trials
organisation collaborative initiative. Arthritis Rheumatol.
68:566–576. 2016.PubMed/NCBI View Article : Google Scholar
|
|
218
|
Shalabi H, Gust J, Taraseviciute A,
Wolters PL, Leahy AB, Sandi C, Laetsch TW, Wiener L, Gardner RA,
Nussenblatt V, et al: Beyond the storm-subacute toxicities and late
effects in children receiving CAR T cells. Nat Rev Clin Oncol.
18:363–378. 2021.PubMed/NCBI View Article : Google Scholar
|
|
219
|
Ishida H, Yoshida H, Yoshihara T, Ito M
and Morimoto A: Origin of macrophages involved in the development
of allogeneic hematopoietic stem cell transplantation-associated
hemophagocytic syndrome: Observations on a patient with juvenile
myelomonocytic leukemia. Bone Marrow Transplant. 40:701–703.
2007.PubMed/NCBI View Article : Google Scholar
|
|
220
|
Ostronoff M, Ostronoff F, Coutinho M,
Calixto R, Souto Maior AP, Sucupira A, Florencio R and Tagliari C:
Hemophagocytic syndrome after autologous peripheral blood stem cell
transplantation for multiple myeloma; successful treatment with
high-dose intravenous immunoglobulin. Bone Marrow Transplant.
37:797–798. 2006.PubMed/NCBI View Article : Google Scholar
|
|
221
|
Koyama M, Sawada A, Yasui M, Inoue M and
Kawa K: Encouraging results of low-dose etoposide in the treatment
of early-onset hemophagocytic syndrome following allogeneic
hematopoietic stem cell transplantation. Int J Hematol. 86:466–467.
2007.PubMed/NCBI View Article : Google Scholar
|
|
222
|
Ono R, Ashiarai M, Hirabayashi S, Mizuki
K, Hosoya Y, Yoshihara H, Ohtake J, Mori S, Manabe A and Hasegawa
D: Ruxolitinib for hematopoietic cell transplantation-associated
hemophagocytic lymphohistiocytosis. Int J Hematol. 113:297–301.
2021.PubMed/NCBI View Article : Google Scholar
|
|
223
|
Janka GE: Familial hemophagocytic
lymphohistiocytosis. Eur J Pediatr. 140:221–230. 1983.PubMed/NCBI View Article : Google Scholar
|
|
224
|
Messina C, Zecca M, Fagioli F, Rovelli A,
Giardino S, Merli P, Porta F, Aricò M, Sieni E, Basso G, et al:
Outcomes of children with hemophagocytic lymphohistiocytosis given
allogeneic hematopoietic stem cell transplantation in italy. Biol
Blood Marrow Transplant. 24:1223–1231. 2018.PubMed/NCBI View Article : Google Scholar
|
